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In vitro selection of a viomycin-binding RNA pseudoknot 
Mary G Wallisl, Barbara Streicher l, Herbert Wankl”, Uwe von Ahsenl+, 
Elisabeth Clod?, Scot T Wallace’, Michael Famulok2 and Ren6e Schroeder’ 
Background: The peptide antibiotic viomycin inhibits ribosomal protein 
synthesis, group I intron self-splicing and self-cleavage of the human hepatitis 
delta virus ribozyme. To understand the molecular basis of RNA binding and 
recognition by viomycin, we isolated a variety of novel viomycin-binding RNA 
molecules using in vitro selection. 
Results: More than 90% of the selected RNA molecules shared one 
continuous highly conserved region of 14 nucleotides. Mutational analyses, 
structural probing, together with footprinting experiments by chemical 
modification, and Pb2+-induced cleavage showed that this conserved sequence 
harbours the antibiotic-binding site and forms a stem-loop structure. Moreover, 
the loop is engaged in a long-range interaction forming a pseudoknot. 
Conclusions: A comparison between the novel viomycin-binding motif and the 
natural RNA target sites for viomycin showed that all these segments form a 
pseudoknot at the antibiotic-binding site. We therefore conclude that this 
peptide antibiotic has a strong selectivity for particular RNA pseudoknots. 
Introduction 
Numerous antibiotics interact with RNA, as confirmed by 
a plethora of observations over many years. Interactions of 
antibiotics with the ribosome have been the focus of such 
antibiotic studies [l] and more recently, group I introns 
have been shown to interact with a multitude of chemi- 
cally different small molecules, including structurally 
diverse antibiotics from the aminoglycoside [2,3], peptide 
[4], and pseudodisaccharide families [S]. Generally, these 
antibiotics inhibit RNA function, but in two cases the 
peptide antibiotics from the tuberactinomycin family stim- 
ulate RNA activity. In the first case, viomycin enhances 
the cleavage reaction of the ribozyme derived from the 
Neurospora crassa VS RNA [6]. In the second, both disrup- 
tion of the self-splicing activity of group I introns [4] and 
the induction of intron oligomerization [7] have been 
shown to occur in the presence of viomycin. Recently, it 
was reported that viomycin inhibits the self-cleavage activ- 
ity of the human hepatitis delta virus (HDV) ribozyme [8]. 
Our aim is to understand the principles underlying binding 
and recognition of antibiotics by RNA. Many pathogen- 
specific RNA molecules are inhibited by antibiotics 
(reviewed in [9]) and retrovirus-derived diseases are in 
urgent need of therapy. The development of novel drugs 
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targeted against pathogen-specific RNA molecules requires 
a detailed understanding of the interactions between RNA 
and small molecules. 
Zn vitro selection and evolution has allowed the exploration 
of many facets of RNA activity including the identification 
of unique binding and catalytic properties (reviewed in 
[lo]). We sought to investigate the fundamental nature of 
antibiotic-RNA interactions with a view to understanding 
the manner in which antibiotics disturb intrinsic RNA 
functions. The possibility that the specific recognition of 
RNA molecules by antibiotics implicates common struc- 
tural targets has recently been investigated for a variety of 
aminoglycoside antibiotics. Three independent studies 
sieved different random-sequence pools for RNA mol- 
ecules which specifically bound neomycin [ 111, tobramycin 
[12], kanamycin A or lividomycin [13]. Zn vitro selection led 
to the isolation of small RNA molecules which were 
amenable to molecular characterization, in contrast to the 
‘classic’ biological RNA molecules which, owing to their 
size, often require dissection before structural information 
is accessed [14-161. 
In this study, we used in vitro selection to isolate apta- 
mers which specifically recognize the peptide antibiotic 
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Figure 1 
R 
The cyclic peptide antibiotic viomycin (R=OH) and its analogue 
tuberactinomycin 0 (R=H). 
viomycin. Characterization of these small molecules 
showed that almost all the selected RNA molecules con- 
tained a region of highly conserved sequence. This ‘con- 
sensus’ region was shown to contribute to the formation of a 
pseudoknot structure and to harbour the site of interaction 
with viomycin. 
The knowledge that resistance to antibiotics provides a 
relentless threat [17] gives substantial impetus to attempts 
to advance our understanding of antibiotic ‘behaviour’, 
including antibiotic-RNA interactions. Our studies 
provide an insight into certain structural fundamentals 
underlying these interactions and they demonstrate that in 
vitro selection is an appropriate tool for the isolation of 
synthetic receptors. 
Results 
Isolation of viomycin-binding RNA molecules 
Using in vitro selection, we isolated novel RNA mol- 
ecules which specifically recognize the cyclic peptide 
antibiotic viomycin (Figure 1). The initially randomized 
RNA pool, of approximate complexity lo’“, comprised 
molecules containing a 74 nucleotide core of random 
sequence [18]. This pool was subjected to seven cycles 
of viomycin-affinity chromatographic selection: RNA 
molecules specifically retained on the antibiotic-deriva- 
tized sepharose column were affinity-eluted with selec- 
tion buffer containing 2SmM viomycin. The course of 
the selection is summarized in Table 1. In order to 
enrich the pool with a more homogeneous population of 
molecules, the number of washes prior to affinity elution 
was increased from the fourth cycle onwards. By the 
seventh selection cycle, the percentage of viomycin- 
binding RNA molecules that could be eluted had 
reached saturation. 
After seven cycles of selection, the RNA population that 
had been successively enriched with molecules recognizing 
Table 1 
Viomycin in vitro selection summary. 
Selection Number of Number of RNA affinity- 
cycle number buffer washes affinity washes eluted (O/o) 
1 5 2 0.02 
2 5 2 0.25 
3 5 2 0.25 
4 5 2 19 
4 bis 30 2 1.5 
5 40 2 6.3 
6 30 2 22 
7 30 2 23 
Selection cycles and number of buffer washes prior to the viomycin- 
affinity washes are indicated, where one wash represents one column 
volume. The progression of the selection was monitored by 
determining the percentage (a/o) of the input RNA which was affinity- 
eluted with viomycin from the antibiotic-derivatized chromatography 
column. Cycle 4 bis is the repetition of cycle 4 with an increased 
number of washes. 
viomycin was cloned as described previously [ 1 l] and the 
sequences of individual clones were determined. The vari- 
ability of the sequences was high: in a total of 23 different 
sequences only one was isolated repeatedly (violl8, six 
times), but over a short stretch of 14 nucleotides (SG,C,- 
U,G,A,A,A,G,G~P,,U,,C,,G,,C,,3’), the different clones 
were closely related at the primary sequence level 
(Figure 2). In this highly conserved consensus sequence, 
eight invariant bases and two nonconserved bases occurred 
(&+G in three out of 21 clones and A+ in two cases). 
At both the 5’ and 3’ extremities of the conserved sequence 
two covariant bases suggested that a stem structure closes 
the motif. In addition to the conserved sequence, bases in 
the regions upstream and downstream of this consensus 
sequence had the potential to pair, thus leading us to 
propose a stem-loop structure for the motif (Figure 3). 
Determination of & for individual clones 
From the enriched RNA pool, the viomycin-binding 
behaviour of several representative clones was deter- 
mined. Individual RNA molecules were chosen on the 
basis of the primary sequence variation within the con- 
served motif and on the position of this motif within the 
full-length clone. The ability of individual clones to recog- 
nize viomycin specifically was verified by affinity chro- 
matography, and all RNA molecules tested showed similar 
affinity for viomycin. Gel filtration analysis using 14C- 
labelled viomycin was used to determine the dissociation 
constants (Kds) for antibiotic binding in solution. The dis- 
sociation constants for RNA molecules matching the con- 
sensus sequence fell into the range 11-21 p,M (Table 2). 
Probing the structure of in vitro selected RNA molecules and 
their interaction with viomycin 
Folding of the individual full-length sequences using the 
Zuker RNA-folding program [19] and the covariation shown 
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Figure 2 
viol : ggagcucagccuucacu ggauggacucugcuaucggacugaagccaguugguggucagcccacaugcggaggguucccggcaccacggucggauccac 
vio2: ggagcucagccuucacugcaccgguggcguguggccuagcuccaggccaaguuguggc uccacagcagaggugcucuuuggcaccacggucggauccac 
vio3: ggagcucagccuucacugcguagcgcguauuggcug aagagagucuccaugaucggcaccacggucggauccac 
vio9: ggagcucagccuucacugcucaagcaaaucugccgcu uugguaggugugaagguacuauaggcaccgcgauuguggcaccacggucggauccac 
vio12: ggagcucagccuucacugccucagggcgggugaagg ucuaaaaggccauguguagccaccacugaugugggcgcggcaccacggucggauccac 
viol5: ggagcucagccuucacu acugaccaauucaguuggucuacgaucgucgccgaaaacggcaccacggucggauccac 
vio22: ggagcucagccuucacu caauagcggggugggaacugccgucaguucuccaucucguugggcaccacggucggauccac 
vio24: ggagcucagccuucacugcauggcggcugaggcggc guuauuccuucggccguagucuggcaccacggucggauccac 
vio52: ggagcucagccuucacugcgagcguugggcugagugc gagcagcugccugugcaacggcaaucuguuguacugcaggcaccacggucggauccac 
vio74: ggagcucagccuucacugcauuggcugaguuaguguu cuacgcgggaaacugcaugacuuaaugauaugcgguggcaccacggucggauccac 
viol 09: ggagcucagccuucacu uucggaggaccagcgagcuccgugauuguggcagcuaguggcaccacggucggauccac 
viol 11: ggagcucagccuucacu gguguggcgaacagucgaaugcggcacguucaccauagagagcucccgaucggcaccacggucggauccac 
viol 12: ggagcucagccuucacugcuau ccuggacugucucuccaguggccgagguugcuuggcaccacggucggauccac 
viol 13: ggagcucagccuucac cggugcaucaaucccuggggcuauggguucguuggcaccacggucggauccac 
viol 14: ggagcucagccuucac ucauugagcugcgcggccaugggacucauccgaggcaccacggucggauccac 
viol 10: ggagcucagccuucacu 
viol 20: ggagcucagccuucacu 
viol 25: ggagcucagccuucacu 
viol 27: ggagcucagccuucacu 
vio128: ggagcucagccuucacu 
viol 29: ggagcucagccuucacu 
viol 30: ggagcucagccuucacu 
viol 45: ggagcucagccuucacu 
The primary sequence of 23 individual clones comprising the pool after originally degenerate core region (74 nucleotides) plus the defined 
the seventh cycle of selection The clone number is shown on the left. flanking regions that enable primer binding. Nucleotides matching the 
The sequences shown represent the full-length RNA molecules in the consensus sequence are shown in bold and in block shading. 
in Figure 3 suggest that the region of primary homology forms 
a stem-loop secondary structure. Chemical modification was 
undertaken to determine whether individual RNA molecules 
formed the proposed stem-loop motif represented by the 
computer generated folding, to examine whether the primary 
sequence covariations (mentioned above) indeed reflected a 
conserved structural feature, and to localize the regions within 
individual selected clones which interact with viomycin. 
RNA clones vio74, viol30 and viol45 (see Figure 2) were 
selected for further characterization and the chemical 
Figure 3 
AT---WC 
Variations of the consensus sequence proposing a stem-loop 
structure. 
modification agents dimethyl sulphate (DMS), kethoxal or 
1-cyclohexyl-(Z-morpholinoethyl)-carbodiimide metho-p- 
toluene sulphonate (CMCT) were used specifically to 
modify accessible bases [ZO]. Positions on the full-length 
RNA molecules that could be modified were revealed by 
primer extension of an annealed oligonucleotide. A typical 
modification pattern is shown in Figure 4 for the clone 
viol45 The secondary structure proposed by the Zuker 
RNA folding algorithm and the chemical modification 
pattern of the RNA molecules (in the absence of antibiotic) 
were generally in agreement (i.e. the computer-predicted 
base-paired regions were protected from modification). 
The chemical modification data suggested that bases G, 
Table 2 
Summary of the dissociation constants (K,,s) for the binding of 
viomycin to selected RNA molecules. 
Aptamer Motif feature K, (04 
viol 12 Consensus 11.6f2 
viol 45 Consensus 13.1 +6 
vi074 Stem C2G13 to UA 12.6f2 
viol30 Stem Gl Cl 4 to CG 15.9f3 
viol 11 Loop A6 to G 21.0f3 
vi052 Loop A7 to C 15.0f4 
The numbering scheme for the conserved sequence motif is as 
follows: 5’G C U G A A A G G A U C G C 3’. The K, 1 2 3 4 5 6 7 6 9 10 11 12 13 14 
measurements were determined for the full-length clones. The K, 
values were calculated from at least three independent experiments. 
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Figure 4 
Gl, 
G4, 
GQ- 
GQ. 
G13, 
- - 
Chemical modification of the selected RNA viol 45, in the presence 
and absence of viomycin. For the specificities of the chemically 
modifying agents see the Materials and methods section. A (adenine) 
and G (guanine) denote dideoxy sequencing lanes (note that in the 
sequence lane, the bands are one nucleotide longer than in the 
corresponding chemical modification lane, because after modification 
the corresponding nucleotide is no longer incorporated by the reverse 
transcriptase). K, control (i.e. no modification); -, no viomycin; 
otherwise the antibiotic concentrations were 10 FM and 100 FM 
as shown. 
and C, paired with C,, and Gr3, respectively, an interaction 
that is corroborated by sequence covariation (Figure 3). 
The Watson-Crick positions of Us were not accessible to 
modification with CMCT but were modified by DMS 
(Figure 4 and data not shown). Positions Nl and N2 of 
G, were not accessible to kethoxal modification. Posi- 
tions A,-A, were modified by DMS and G, was modified 
by kethoxal (Figure 4). Positions G,-C,, were not acces- 
sible to modification, suggesting that they are involved 
in base pairing. 
Chemical modification of the native RNA structures com- 
plexed with 10pM or 1OOp.M viomycin was also under- 
taken. Four adjacent positions clearly showed protection 
by viomycin against modification from DMS (Figure 4 and 
data not shown). These positions are located in the loop of 
the conserved sequence: the unusually modified U,, posi- 
tion N7 of G, and position Nl of A, and &. The Nl and 
N’2 positions of G,, modifiable by kethoxal, were also pro- 
tected by viomycin. All the RNA molecules tested 
revealed a similar ‘footprint’ of protected bands, which was 
solely located within this conserved motif. Consistent with 
the idea that invariant positions in RNA molecules are 
potentially indicative of ‘functional bases’, the protection 
afforded by viomycin is notably stronger at G, and A, than 
at A,. Interestingly, these two bases are at positions which 
are absolutely conserved among the selected RNA mol- 
ecules bearing the consensus sequence (Figures 2,3). 
Variant viol 11, which has an A,+G mutation, has a lower 
affinity for viomycin than the clones which completely 
match the consensus sequence at these positions (Table 2). 
Pb2+-induced cleavage of viomycin-binding RNA molecules 
In addition to the chemical modification analysis, we used 
Pb*+-induced RNA cleavage to probe the structures of our 
novel viomycin-binding RNA molecules and to analyze 
their interaction with viomycin. Cleavage was induced in 
5’ 3*P-labelled RNA molecules upon exposure to Pb(OAc), 
under the conditions described in the Materials and 
methods section [Zl]. Cleavage positions were identified 
by comparison with a Tl digestion ladder (see Materials 
and methods section). Figures 5a and 5b show representa- 
tive analyses for the selected clones viol30 and viol45 
respectively. Pbz+-induced cleavage occurred predomi- 
nantly at phosphate positions in single-stranded regions. 
This correlates well for each case (clones vio74, viol30 and 
vio145) with the secondary structures proposed by the 
Zuker RNA folding algorithm and by chemical modifi- 
cation. The cleavage pattern shows that not all the back- 
bone positions within the loop are equally accessible. Two 
sites exist at which strong cleavage occurs readily: 3’ of A, 
and U,,. Although Pb2+ preferentially hydrolyzes single- 
stranded RNA, cleavage may occur in double-stranded 
regions if they contain weak, bulged or destabilized base 
pairs. In addition to the major sites of cleavage, several 
contiguous positions of moderate or weak cleavage occur 
which correspond to the region of the loop at which a foot- 
print by viomycin is observed. The presence of numerous 
adjacent Pb2+-cleavage sites has been proposed to reflect a 
region of high flexibility [‘Zl]. Another remarkable feature 
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of this loop structure appears to be the region of the back- 
bone Gs-A,,, where the phosphates show extremely low 
accessibility to Pba+-promoted hydrolysis. This suggests 
that this side of the loop may be involved in a structural 
interaction which protects these three phosphate positions. 
Identical cleavage patterns within this consensus region 
were observed in individual RNA aptamers, suggesting a 
common structural feature of the conserved motif. Taken 
together, the Pbz+-cleavage analyses corroborate the struc- 
tural conclusions of the chemical modification analyses, 
supporting the idea of an irregular stem-loop motif. 
The Pb2+-cleavage assay was carried out in the presence of 
viomycin in an attempt to identify the viomycin-binding 
site within the full-length RNA molecules and to test 
whether there were any structural changes upon 
viomycin-RNA complex formation. Viomycin protected 
several positions in the conserved consensus region from 
cleavage, as seen in the Pb*+-induced hydrolysis pattern 
(Figure Sa,b and data not shown). The most dramatic 
effect was seen at phosphate positions to the 3’ side of A, 
and Ull, where the cleavage was strongly inhibited in the 
presence of 1OOp.M viomycin. The position 3’ of C,,, 
which showed a moderate cleavage signal, was also pro- 
tected upon addition of viomycin. These results show that 
the binding of the peptide antibiotic viomycin to the in 
vitro selected RNA molecules protects certain backbone 
positions which are located within the consensus motif. 
The protection may either be the result of a direct inter- 
action of the antibiotic with specific phosphates and/or it 
may result from the loss of flexibility of the backbone 
upon viomycin binding. Figure 5c summarizes the results 
obtained from chemical modification and Pb2+-cleavage. 
The high degree of sequence conservation, the results of 
chemical modification and the Pb2+-cleavage data encour- 
aged us to construct a short oligoribonucleotide consisting 
of the conserved loop with a stem containing six base pairs 
(data not shown). This short RNA was tested in a PbZ+- 
cleavage assay in the absence and presence of viomycin to 
test whether the Pbz+-cleavage pattern would reflect a 
Figure 5 
Structural probing of the viomycin-binding RNA molecules with 
Pb(OAc), in the absence and presence of viomycin. The cleavages 
were carried out in buffer containing 200 mM NaCl and 5 mM MgCI,. 
Lanes marked ‘-’ and ‘no Pb*+’ contain non-incubated and incubated 
RNA, respectively, in the absence of Pb(OAc),. Pb*+-induced 
cleavage was performed in the presence of various concentrations of 
viomycin as indicated above the corresponding lane. Tl represents the 
partial RNAse Tl digestion, with cleavage positions at the 3’side of 
preferentially single-stranded guanine bases. The nucleotide 
numbering scheme is based on the conserved sequence motif as 
follows: 5’G C U G A A A G G A U C G C 3’. (a) RNA 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
derived from clone viol 30. (b) RNA derived from clone viol 45. 
(c) Summary of protections from chemical modification and Pb*+ 
cleavage by viomycin in the consensus region. 
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structure similar to the full-length clone and whether the 
same protection would appear with viomycin. The short 
construct showed a similar Pbz+-cleavage pattern with the 
strongest cleavage at positions A, and U,,. But positions 
Gs-A,, were much more sensitive to Pbz+ cleavage than in 
the full-length construct. Viomycin still protected the cleav- 
age at position A,, although it was tenfold less efficient 
than for the full-length clone. The cleavage at U,, was not 
protected by viomycin (data not shown). From these results 
we concluded that the conserved stem-loop alone is not 
sufficient to achieve full viomycin-binding activity. 
Interference studies suggest that the conserved motif is 
not sufficient for binding 
To determine the minimal motif capable of high-affinity 
binding of viomycin, individual RNA molecules were par- 
tially hydrolyzed (as described previously [ll]) and then 
subjected to affinity chromatography. RNA molecules that 
retained binding capability were affinity-eluted and com- 
pared with total non-selected partially hydrolyzed RNA 
molecules. These experiments confirmed that the hairpin 
motif alone is not sufficient for binding. Although all 
clones tested could be shortened from the 5’ side, none of 
the clones tolerated shortening from the 3’ side (data not 
shown). From these observations, we concluded that the 
extreme 3’ end of the molecules is essential for viomycin 
binding. The bases in the 3’ terminal sequence 5’GAU- 
CC 3’, which is part of the invariant flanking sequence that 
provides primer binding sites for amplification, have the 
potential to pair with bases Gs-C,z of the conserved motif. 
Mutational analyses identify a pseudoknot motif for 
viomycin recognition 
All the clones contain a S’GAUCC3’ sequence, which is 
part of the invariant primer used for amplification and 
which has the potential to base pair with sequences within 
the conserved loop. We tested whether these sequences do 
indeed undergo base pairing. The following variants of 
clone viol45 were constructed: positions G, and A,, in the 
conserved loop were mutated to A, and G,, and the 3’ ter- 
minal sequence S’GAUCC3’ was mutated to S’GACUC 3’, 
both of which should disrupt the suspected pairing; and a 
compensatory combination of both mutants, which should 
restore the pairing. The K, values of the wild-type clone 
viol45 and the three variants were determined by gel Iil- 
tration analysis. The results are shown in Figure 6a. 
The variants which disrupt the potential base-pairing have 
an almost twofold lower affinity for viomycin, whereas the 
compensatory mutation restores binding affinity almost to 
the wild-type level. These experiments suggest that the 3’ 
terminal sequence S’GAUCC 3’ interacts with the sequence 
S’GGAUC3’ in the conserved loop, which results in the 
formation of a pseudoknot. 
The formation of the pseudoknot was further tested by 
constructing a variant of clone viol45 which lacked the 
last six nucleotides, five of which are thought to form the 
pseudoknot. This RNA was analyzed by chemical modifi- 
cation with DMS and kethoxal in the absence or presence 
of viomycin (Figure 6b). The results from this experiment 
were in good agreement with the results of Figure 6a. . 
Posmons G,, A,, and CrZ, which were not accessible to 
modification in the full-length RNA, were accessible to 
modification by kethoxal and DMS in the RNA lacking 
the final nucleotides. This was as expected if the missing 
bases were the pairing partners for the pseudoknot forma- 
tion. In addition, the footprint, which was observed in the 
presence of viomycin in the full-length RNA, disappeared 
in the shortened clone, indicating that viomycin was no 
longer binding to the region U,-A, of the loop. 
To further verify the importance of the pseudoknot for 
viomycin binding, the wild-type clone vio145, the 
mutant A,G,,, the compensatory mutant restoring the 
pseudoknot and the variant lacking the 3’ part of the 
pseudoknot were probed with Pb(OAc), in the absence 
or presence of 100 FM and 200 pM viomycin (Figure 6~). 
Pb(OAc)2 induced an additional cleavage to the 3’ side of 
G, in the A,G,, mutant and the compensatory mutants, 
which was protected by viomycin as were A, and U,,. 
Positions A, and U,, of the wild-type and the compen- 
satory mutant were 67% and 60% protected at 100pM 
viomycin, the A,G,, mutant was 33% protected and the 
3’ deletion mutant was only 12% protected. The influ- 
ence of the mutations on viomycin binding was in good 
agreement with the K, values determined via equilib- 
rium gel filtration. The viomycin binding of the A,G,,, 
mutant was two-fold lower than for the wild-type; the 
viomycin binding of the compensatory mutant was com- 
parable to that of the wild-type; and the viomycin 
binding of the 3’ deletion totally lacking the pseudoknot 
was almost ten-fold lower. 
These data are consistent with the formation of a pseudo- 
knot which is essential for viomycin binding, and the pro- 
posed secondary structure of clone viol45 is given in 
Figure 6d. 
Discrimination between viomycin and its analogue 
tuberactinomycin 0 
To get an idea of whether the selected motif binds 
viomycin in a similar way to the self-splicing group I 
intron, the viomycin analogue tuberactinomycin 0, which 
is not an inhibitor of splicing [4], was tested for its binding 
to the clone viol45 Clone viol45 was analyzed by Pb2+ 
cleavage in the presence of ZOOp,M viomycin or tuber- 
actinomycin 0. As can be seen from Figure 7, viomycin 
strongly protects positions A, and U,, from Pb2+ cleavage, 
whereas tuberactinomycin 0 does not. This is a first indi- 
cation that the hydroxyl group, which is missing in tuber- 
azctinomycin 0, is essential for binding to the in a&o 
selected RNA pseudoknot, as it is for inhibiting splicing. 
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Discussion small recurring motifs recognized by viomycin, which 
Viomycin, a small cyclic peptide antibiotic (Figure l), would be amenable for structural determination, 
specifically recognizes a diverse set of highly structured, 
functional RNA molecules. To achieve a better under- Our selection identified one commonly recurring motif, a 
standing of the minimal requirements governing viomycin- pseudoknot, which is important for binding viomycin. 
RNA interactions, we aimed to isolate and characterize The population of viomycin-binding RNA molecules 
Figure 6 
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Determination of Kd values for variants of clone viol 45 disrupting and 
restoring the proposed long-range interaction. (a) Equilibrium gel 
filtration determination of the K, value for viol 45 with 14C-viomycin in 
solution. The figure shows the relative radioactivity (where 1 OOo/, is the 
activity of the running buffer) versus the fraction number (39.4 JLI). The 
peak corresponds to the viomycin-RNA complex. (b) Chemical 
modification of a variant of clone viol 45 lacking the last six 
nucleotides, resulting in the disruption of the proposed pseudoknot. 
Lane annotations and experimental procedures are as described in 
Figure 4. (c) Footprinting viomycin interactions with variants of clone 
viol 45. Mutant AsG,,, the compensatory mutant which restores the 
pseudoknot, and the variant lacking the 3’ part of the pseudoknot were 
incubated with Pb(OAc), in the absence (lane 2) or in the presence of 
100 FM (lane 3) or 200 FM (lane 4) viomycin. Tl is the partial RNase 
Tl digestion, OH- the partial alkaline hydrolysis ladder, and lane 1 is 
RNA only. (d) Proposed secondary structure of clone viol 45 with the 
pseudoknot. 
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Clone viol 45 was tested for discrimination between viomycin and 
tuberactinomycin 0 (see Figure 1). Pb(OAc), cleavage was done in 
the absence or presence of 200 JLM viomycin or tuberactinomycin 0 
(see Figure 5). 
obtained from our selection shows a remarkable homo- 
geneity, not only reflected in their sequence motif but 
also in their K, values for viomycin (see Table 2). Most 
RNA molecules have K,= 11-16p,M viomycin, one clone 
(violll), however, has a lower affinity (21 FM), which 
could be explained by the variation in the consensus 
sequence (A,-+G; a position shown to be protected by 
viomycin from DMS modification; Figures 4,s~). The 
binding constants for the in ah-o selected RNA molecules 
are comparable with interactions observed for natural 
viomycin-RNA complexes. Viomycin inhibits group I 
intron self-splicing at 17-50 pM (depending on the intron 
[4]) and the HDV genomic and antigenomic ribozymes at 
35 p.M and 100 p,M, respectively [8]. It must be taken into 
consideration, however, that these are Ki and not K, 
values, and that the ionic conditions under which they 
were determined were not uniform. 
The selection procedure resulted in the isolation of one 
dominant sequence motif (Figure 2) with the consensus 
SGCUGAAAGGAUCGC 3’. The secondary structure of 
the motif is a stem-loop, the stem of which is corroborated 
by structural covariation and by chemical modification 
(Figures 3,4). The loop is not unstructured and is involved 
in a long-range interaction with sequences near the 3’ end 
of the RNA, resulting in the formation of a pseudoknot. 
While the 5’ half of the loop is accessible to modification, 
the 3’ part is not, suggesting that positions G,-C,z are 
pairing with the distal 3’ end. By removing the last six 
nucleotides at the 3’ end of the RNA, positions G,, A,, 
and C,, become accessible to modification (Figure 6b). 
Unusual features of the loop involve the DMS modifica- 
tion of U, and the inaccessibility of the Nl and N’2 posi- 
tions of G, to kethoxal. Bases U, and G, might be 
protected by the deep groove of the helix formed between 
positions G&i, with the 3’ distal sequence S’GAUCC3’. 
This is consistent with the structure of single-stranded 
loops in pseudoknots [22,23]. DMS does not usually 
modify uridines, but a high pH value has been shown to 
result in the modification of uridines by DMS [24]. The 
microenvironment of U, might result in this modified 
behaviour with respect to DMS. Positions A, and U,, 
show a high sensitivity to PbZ+ cleavage, which might 
result from a high flexibility of the backbone [Zl] or from 
a high-affinity metal ion binding site [ZS]. Addition of 
viomycin to the RNA results in protection of positions U, 
to A, from chemical modification and protection of posi- 
tions A, and U,, from Pb2+ cleavage. These protections 
clearly demonstrate that this region of the RNA molecule 
harbours the viomycin-binding site. 
Viomycin has the remarkable characteristic of inducing 
RNA-RNA interactions. Several reports underline this 
fact: viomycin stimulates oligomerization of group I 
intron RNA by shifting the intramolecular circularization 
to an intermolecular transesterification leading to intron- 
multimers [7]; the cleavage reaction of the ribozyme 
derived from N. crassu VS RNA is enhanced by viomycin, 
which decreases the required Mgz+ concentration by an 
order of magnitude and stimulates a trans-cleavage reac- 
tion [6]; viomycin has a binding site on each ribosomal 
subunit of the Eschetichia co/i ribosome [26,27] and it 
inhibits subunit dissociation and translocation [28,29]; 
and viomycin interferes with binding of the ternary 
complex to the ribosomal A site for codon-anticodon 
interactions containing a mismatch. It was concluded that 
viomycin increases the binding of mismatched codon- 
anticodon pairs by providing the same amount of binding 
energy as a base pair [30]. All these observations suggest 
that viomycin has more than one contact site with the 
RNA, a characteristic which results in a stimulation of 
intermolecular RNA interactions or in the stabilization of 
the tertiary structure. This characteristic is reminiscent 
of the mode of binding of another peptide antibiotic, 
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thiostrepton, which bridges two loops of domain II of 23s 
rRNA [ 161. 
The result of our selection prompted us to compare the 
natural viomycin target sites with our novel pseudoknot 
motif; all those that have been characterized fold into a 
pseudoknot structure. Viomycin protects positions A,,,- 
A,,, of the 16s ribosomal RNA of E. co/i from DMS modi- 
fication. Positions immediately to the 3’ side of AsIs, 
namely U916-~ls~ interact with positions U,,-A,, forming 
the central pseudoknot of 16s rRNA, which has been sug- 
gested to be involved in the regulation of translation accu- 
racy [26,31]. Positions 913-915 of the 16s rRNA are three 
consecutive adenines. In the pseudoknot isolated via in 
vitro selection, three consecutive adenines are found in the 
loop, two of which, A, and A,, are protected by viomycin. 
Viomycin is a competitive inhibitor of group I intron self- 
splicing, and one contact site on the intron RNA was 
shown to be the guanosine-binding site [4], which is 
located in the P7 stem, a pseudoknot in the core of the 
ribozyme [32,33]. Another ribozyme, which is inhibited by 
viomycin and whose structure is proposed to be a pseudo- 
knot, is derived from the human HDV RNA [8,34,35]. 
Further structural characterization of these pseudoknots 
will have to be undertaken to gain a better understanding 
of the commonalities of the viomycin-binding sites. The 
function of RNA pseudoknots is, as yet, unclear, but they 
are mostly located in flexible and essential parts of RNA 
molecules (reviewed in [36]). Thus, taken together, the 
results of our selection and the fact that the natural target 
sites for viomycin are composed of RNA pseudoknots 
suggest that this peptide antibiotic has a specificity for, and 
is able to recognize, particular pseudoknots. 
Significance 
Viomycin is a small cyclic peptide antibiotic containing 
the amino acids a&nine, serine and lysine, of which all 
are known to occur in functional domains of RNA- 
binding proteins. Viomycin inhibits translation and splic- 
ing of group I introns and it induces RNA-RNA 
interactions. To gain a better understanding of the basic 
principles underlying binding and recognition of 
viomycin by RNA, we used in vitro selection to isolate a 
variety of viomycin-binding RNA molecules. The 
selected RNA molecules shared one commonly recur- 
ring motif, a pseudoknot, which is important for binding 
viomycin. The K, values for viomycin were 11-16 PM, 
comparable with interactions observed for natural 
viomycin-RNA complexes. Addition of viomycin to the 
RNA results in protection from chemical modification 
of bases within the consensus motif and protection of 
backbone positions from Pb2+ cleavage, confirming that 
this region is involved in viomycin binding. By compar- 
ing the natural viomycin target sites with our novel 
pseudoknot motif, it was noticed that they all fold into 
pseudoknot structures. Because all the RNA molecules 
isolated in this selection have the potential to form 
pseudoknots, we suggest that the binding site for 
viomycin is embedded in an RNA pseudoknot structure. 
Our results further demonstrate the advantage of using 
random sequence RNA molecules for the isolation and 
characterization of small aptamers with specific ligand- 
binding affinity. Thus, basic principles can be revealed 
which would otherwise escape our attention due to the 
complexity of the natural antibiotic targets. 
Materials and methods 
Viomycin affinity chromatography selection procedure 
The selection protocol was modified from a previously described pro- 
cedure [l 11. The original random sequence RNA pool construction 
was described previously [37]. This pool consisted of degenerate RNA 
molecules with a core region of 74 nucleotides of random sequence 
flanked by defined regions (total length 1 13 nucleotides) to allow PCR 
amplification. The initial complexity of the pool was -lOI different 
molecules. 
Affinity-matrix chromatography: the ligand viomycin (obtained as the 
sulphate from the Sigma Chemical Company) was immobilized on 
epoxy-activated Sepharose 6B (purchased from Pharmacia Biotech) 
following the manufacturer’s recommendations. The concentration of 
covalently-coupled ligand was estimated to be 1 mM by monitoring the 
UV chromophore of viomycin. The affinity chromatography column was 
equilibrated in selection buffer (5mM MgCI,, 50mM Tris-HCI pH 7.6, 
250mM NaCI), the bed volume of the viomycin-derivatized sepharose 
used throughout the selection was 1 ml. 
Selection procedure: 32P-labelled RNA in selection buffer was applied 
to the viomycin-derivatized sepharose. The chromatography column 
was rinsed with selection buffer prior to the elution of RNA molecules, 
specifically binding viomycin, with affinity buffer (selection buffer con- 
taining 2.5 mM viomycin; Table 1). The RNA molecules specifically 
eluted with viomycin were converted to DNA, amplified by PCR, and 
transcribed into RNA. This set of procedures constitutes one selec- 
tion cycle. The resultant purified RNA was the input for the subse- 
quent round of selection. In order to avoid the inadvertent selection of 
matrix-binding or non-specifically-binding RNA molecules, and to maxi- 
mize the enrichment of RNA molecules recognizing viomycin with 
high-affinity and specificity, precautions were undertaken as previously 
described (111. 
Equilibrium gel filtration 
Dissociation constants (K,) were determined in solution using the 
method of equilibrium gel filtration [381. Viomycin was radioactively- 
labelled as described [39] using 20kmol of viomycin (Sigma) and 
20 kmol 14C-urea (Amersham). After labelling, viomycin was separated 
from urea by a Sephadex Gl 0 column. To verify that the urea label was 
incorporated into the viomycin, splicing inhibition and oligomerization 
induction assays were performed (data not shown and [4,401). RNA 
(470pmol) was suspended in buffer (50~1; 5mM MgCI,, 50mM Tris- 
HCI pH 7.4, 50mM NaCl unless otherwise indicated) containing 
14C-labelled viomycin (I and was applied to a Sephadex G25 
Superfine gel column (Pharmacia Biotech; Emm corresponding to 
1.6 ml). The position of the RNA elution peak was verified with radioac- 
tively-labelled RNA and unlabelled viomycin. The radioactivity of the 
individual fractions (39.4 ~1) was quantified by scintillation counting. 
The amount of viomycin bound to the selected RNA molecules was 
determined by calculating the area under the peak, which corresponds 
to the viomycin-RNA complex. The resultant Kd values were determined 
from the formula: K,= [SxL] / (IS] x [Ll, where [SxLl is the fraction 
bound in the elution volume (mol I-l), [S] =concentration of RNA in the 
elution volume (mol I-l), and [L] is the concentration of the ligand in the 
elution volume in (mol I-‘). Experiments were done at least in triplicate. 
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Chemical modification experiments 
Chemical modification of RNA was carried out principally as previously 
described [l 11. The chemical modification agents included: DMS 
which methylates the base-pairing positions Nl of adenine, N3 of cyto- 
sine and also the guanine N7 position; kethoxal, which modifies the 
positions Nl and N2 of guanine; and CMCT, which modifies the Nl 
and N3 positions of guanine and uracil, respectively. Minor alterations 
to this reported protocol were as follows: the binding buffer contained 
NaCl in place of NH& 10 pmol of RNA was used, and the CMCT 
solution was 80 mg ml-l. 
Pb2+-catalyzed cleavage reactions 
5’-End-labelled RNA (-0.5pmol) was equilibrated in buffer (50mM 
Tris-HCI pH 7.7, 5 mM MgCI,, and either 50 mM or 200 mM NaCI) and 
viomycin (100 PM, 200 p,M or 500 FM) for 5 min at room temperature 
(r.t.). Cleavage reactions were initiated by the addition of Pb(OAc), 
(final concentration 0.5 mM in reaction volume 50 p,I). After incubation, 
30 min at r.t., the reaction was stopped by the addition of STOP solu- 
tion (1 ~1; 1 kg p,-l glycogen and 250 mM EDTA). The products were 
recovered by ethanol precipitation, dissolved in loading buffer (7$; 
7 M urea/ 1 xTBE, 0.25% bromophenol blue and 0.25% xylene cyanol) 
and the cleavage reactions were analyzed by electrophoresis. Typically 
8% or 10% polyacrylamide gels (1:20) were used, but for the trun- 
cated RNA molecules, 20% was used. The Tl digestion ladder was 
obtained by incubating 5’-end-labelled RNA with RNase Tl (1 (*I; 
5units JLI-I; Boehringer Mannheim GmbH, Germany) in 7 l.d loading 
buffer containing tRNA (1 p,l; 1.5 IJ-g JLI-I) for 10 min at 50°C. Quantifi- 
cation of the cleavage products was performed using a Molecular 
Dynamics Phosphorimager. 
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